Trials / Completed
CompletedNCT01127529
Ceprotin Treatment Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 43 (actual)
- Sponsor
- Baxalta now part of Shire · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The overall objective is to collect and assess data on the treatment, safety, and treatment outcomes of subjects prescribed, receiving and participating in the Ceprotin treatment registry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Protein C Concentrate (Human) | Commercially available Ceprotin will be prescribed, obtained and administered by the investigator according to local standard of care. |
Timeline
- Start date
- 2010-06-23
- Primary completion
- 2015-06-22
- Completion
- 2015-06-22
- First posted
- 2010-05-21
- Last updated
- 2021-03-17
Locations
28 sites across 6 countries: United States, Austria, Germany, Italy, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT01127529. Inclusion in this directory is not an endorsement.